| David Goldschmid, MD | |
|
4877 Mission St, San Francisco, CA 94112-3413 | |
| (650) 888-2163 | |
| Not Available |
| Full Name | David Goldschmid |
|---|---|
| Gender | Male |
| Speciality | Emergency Medicine |
| Location | 4877 Mission St, San Francisco, California |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1831137025 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | G34004 (California) | Primary |
| Entity Name | Cep America - California |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1023063542 PECOS PAC ID: 6103739131 Enrollment ID: O20031106000520 |
News Archive
AMICAS, Inc., a leader in image and information management solutions, today responded to a press release issued earlier today by Merge Healthcare Incorporated, regarding Merge's acquisition proposal. AMICAS Board of Directors has already considered and publicly rejected Merge's acquisition proposal.
The structure and behavior of one of the most common proteins in our bodies has been resolved at a level of detail never before seen, thanks to new research performed at the Advanced Photon Source (APS) at the U.S. Department of Energy's (DOE) Argonne National Laboratory.
The research team tracked the health and survival of almost 116,000 women who had been diagnosed with primary invasive breast cancer in England and Wales between 1986 and 1990, using information supplied to the National Cancer Registry. Their progress was monitored until 1995.
The Lundquist Institute has received a $1.75 million grant from the Steven & Alexandra Cohen Foundation to fund a multi-site clinical trial to evaluate the efficacy and safety of the compound psilocybin in individuals with severe psychological distress associated with a terminal medical illness.
› Verified 6 days ago
| Entity Name | County Of San Mateo |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1679642326 PECOS PAC ID: 9032023171 Enrollment ID: O20031126000292 |
News Archive
AMICAS, Inc., a leader in image and information management solutions, today responded to a press release issued earlier today by Merge Healthcare Incorporated, regarding Merge's acquisition proposal. AMICAS Board of Directors has already considered and publicly rejected Merge's acquisition proposal.
The structure and behavior of one of the most common proteins in our bodies has been resolved at a level of detail never before seen, thanks to new research performed at the Advanced Photon Source (APS) at the U.S. Department of Energy's (DOE) Argonne National Laboratory.
The research team tracked the health and survival of almost 116,000 women who had been diagnosed with primary invasive breast cancer in England and Wales between 1986 and 1990, using information supplied to the National Cancer Registry. Their progress was monitored until 1995.
The Lundquist Institute has received a $1.75 million grant from the Steven & Alexandra Cohen Foundation to fund a multi-site clinical trial to evaluate the efficacy and safety of the compound psilocybin in individuals with severe psychological distress associated with a terminal medical illness.
› Verified 6 days ago
| Entity Name | County Of San Mateo |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1831268580 PECOS PAC ID: 9032023171 Enrollment ID: O20040123000822 |
News Archive
AMICAS, Inc., a leader in image and information management solutions, today responded to a press release issued earlier today by Merge Healthcare Incorporated, regarding Merge's acquisition proposal. AMICAS Board of Directors has already considered and publicly rejected Merge's acquisition proposal.
The structure and behavior of one of the most common proteins in our bodies has been resolved at a level of detail never before seen, thanks to new research performed at the Advanced Photon Source (APS) at the U.S. Department of Energy's (DOE) Argonne National Laboratory.
The research team tracked the health and survival of almost 116,000 women who had been diagnosed with primary invasive breast cancer in England and Wales between 1986 and 1990, using information supplied to the National Cancer Registry. Their progress was monitored until 1995.
The Lundquist Institute has received a $1.75 million grant from the Steven & Alexandra Cohen Foundation to fund a multi-site clinical trial to evaluate the efficacy and safety of the compound psilocybin in individuals with severe psychological distress associated with a terminal medical illness.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| David Goldschmid, MD 4877 Mission St, San Francisco, CA 94112-3413 Ph: (650) 888-2163 | David Goldschmid, MD 4877 Mission St, San Francisco, CA 94112-3413 Ph: (650) 888-2163 |
News Archive
AMICAS, Inc., a leader in image and information management solutions, today responded to a press release issued earlier today by Merge Healthcare Incorporated, regarding Merge's acquisition proposal. AMICAS Board of Directors has already considered and publicly rejected Merge's acquisition proposal.
The structure and behavior of one of the most common proteins in our bodies has been resolved at a level of detail never before seen, thanks to new research performed at the Advanced Photon Source (APS) at the U.S. Department of Energy's (DOE) Argonne National Laboratory.
The research team tracked the health and survival of almost 116,000 women who had been diagnosed with primary invasive breast cancer in England and Wales between 1986 and 1990, using information supplied to the National Cancer Registry. Their progress was monitored until 1995.
The Lundquist Institute has received a $1.75 million grant from the Steven & Alexandra Cohen Foundation to fund a multi-site clinical trial to evaluate the efficacy and safety of the compound psilocybin in individuals with severe psychological distress associated with a terminal medical illness.
› Verified 6 days ago
Paul Robinson, Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 1230 Arguello Blvd Apt 2, San Francisco, CA 94122 Phone: 415-948-8836 | |
Frederick D Pitts Jr., MD Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 229 7th St, San Francisco, CA 94103 Phone: 415-503-6042 Fax: 415-503-6099 | |
Georgina Lisseth Calderon, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1501 10th Ave, Apt. 1, San Francisco, CA 94122 Phone: 323-514-0964 | |
Timothy Bauer Duncan, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 2333 Buchanan St, San Francisco, CA 94115 Phone: 209-342-2300 Fax: 209-524-4240 | |
Bichhuong M Dinh, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 3555 Cesar Chavez, San Francisco, CA 94110 Phone: 240-447-1281 | |
Dr. Lauren Elizabeth Chalwell, M.D. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 1001 Potrero Avenue Department Of Emergency Medicine, San Francisco General Hospital,, San Francisco, CA 94110 Phone: 415-206-5753 | |
Dr. Jeremy Lacocque, DO Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1001 Potrero Ave, San Francisco, CA 94110 Phone: 628-206-8000 |